Aurinia Pharmaceuticals (AUPH) Other Operating Expenses: 2019-2025
Historic Other Operating Expenses for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Sep 2025 value amounting to -$929,000.
- Aurinia Pharmaceuticals' Other Operating Expenses rose 79.69% to -$929,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.1 million, marking a year-over-year decrease of 9.37%. This contributed to the annual value of $4.3 million for FY2024, which is 151.88% up from last year.
- According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Other Operating Expenses is -$929,000, which was up 89.95% from -$9.2 million recorded in Q2 2025.
- Aurinia Pharmaceuticals' Other Operating Expenses' 5-year high stood at $4.5 million during Q4 2024, with a 5-year trough of -$9.2 million in Q2 2025.
- Over the past 3 years, Aurinia Pharmaceuticals' median Other Operating Expenses value was -$929,000 (recorded in 2025), while the average stood at -$1.7 million.
- Per our database at Business Quant, Aurinia Pharmaceuticals' Other Operating Expenses surged by 1,543.28% in 2021 and then slumped by 3,288.28% in 2025.
- Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Other Operating Expenses stood at $285,000 in 2021, then soared by 661.40% to $2.2 million in 2022, then plummeted by 518.16% to -$9.1 million in 2023, then spiked by 149.66% to $4.5 million in 2024, then soared by 79.69% to -$929,000 in 2025.
- Its Other Operating Expenses was -$929,000 in Q3 2025, compared to -$9.2 million in Q2 2025 and -$4.4 million in Q1 2025.